2006
DOI: 10.1016/j.ijpharm.2006.03.035
|View full text |Cite
|
Sign up to set email alerts
|

Nifedipine solid dispersion in microparticles of ammonio methacrylate copolymer and ethylcellulose binary blend for controlled drug deliveryEffect of drug loading on release kinetics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
39
0

Year Published

2008
2008
2017
2017

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 77 publications
(44 citation statements)
references
References 28 publications
4
39
0
Order By: Relevance
“…After 1 d of incubation, 68.1 wt% of drug was released from microspheres prepared with 5 wt% of daidzein, compared to 45 wt% of drug released from microspheres prepared with 10 wt% of daidzein. A similar phenomenon has also been reported in previous studies, 33,34 and a possible reason is that lower drug loading leads to relatively more drug being located in the region close to the surface of the microspheres. 33 The drug release mechanism from microspheres prepared by emulsification solvent evaporation involves two main processes: (i) an initial burst release of drug located close to microsphere surfaces, (ii) a relatively constant drug release stage depending on drug diffusion and microsphere degradation.…”
Section: Daidzein Release Profilessupporting
confidence: 87%
“…After 1 d of incubation, 68.1 wt% of drug was released from microspheres prepared with 5 wt% of daidzein, compared to 45 wt% of drug released from microspheres prepared with 10 wt% of daidzein. A similar phenomenon has also been reported in previous studies, 33,34 and a possible reason is that lower drug loading leads to relatively more drug being located in the region close to the surface of the microspheres. 33 The drug release mechanism from microspheres prepared by emulsification solvent evaporation involves two main processes: (i) an initial burst release of drug located close to microsphere surfaces, (ii) a relatively constant drug release stage depending on drug diffusion and microsphere degradation.…”
Section: Daidzein Release Profilessupporting
confidence: 87%
“…Consequently, the solubility behavior of a class II drug is the key determinant of its oral bioavailability (2). To date, a considerable number of drugs need to be administered frequently a day because of their short half-life in the body, which results in a significant fluctuation in the plasma drug concentration and drug toxic side effects (3). Therefore, the development of a sustainedrelease oral dosage form instead of the conventional preparations for the side effect reduction and patient compliance improvement is desirable.…”
Section: Introductionmentioning
confidence: 99%
“…Several approaches have been investigated to solve the aforementioned problems, including (a) combining solubilization technology, e.g., solid dispersion, with sustained-release techniques, e.g., a membrane-controlled tablet, and (b) polydisperse systems, e.g., self-microemulsion and nanoparticle (3,4). This method (a) would thus result in a more complex manufacturing process, and careful control of each step would be required to produce reproducible and reliable preparations (5).…”
Section: Introductionmentioning
confidence: 99%
“…In the course of the non-solvent addition, the drug and carrier are co-precipitated to form microparticles. At the end, the resulted microparticle suspension is filtered and dried 58 .…”
Section: Solvent Evaporation Methodmentioning
confidence: 99%